Sanofi Pasteur changes polio vaccination routine in Russia
This article was originally published in Scrip
Executive Summary
Sanofi Pasteur,Sanofi-Aventis's vaccines division, has signed a contract with the Moscow-based Chumakov Institute of Poliomyelitis and Viral Encephalitis (IPVE), part of Russia's Academy of Medical Sciences. The company will supply its inactivated polio vaccine Imovax to Russia at a large discount, and the institute will pack, label and sell it, as well as monitor its quality.